Nev. Admin. Code § 689A.425

Current through September 16, 2024
Section 689A.425 - Coverage for prescription drugs: Removal from approved formulary prohibited; exception; movement to different tier in formulary; addition of drug to formulary
1. Except as otherwise provided in this section, an individual carrier that offers a health benefit plan which provides coverage for prescription drugs and uses a formulary that has been approved by the Commissioner pursuant to NRS 687B.120 shall not:
(a) Remove a prescription drug from the formulary; or
(b) If the formulary includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to the prescription drugs in each tier, move a drug to a tier with a larger deductible, copayment or coinsurance, during the plan year for which the formulary was approved by the Commissioner.
2. An individual carrier described in subsection 1 may:
(a) Remove a prescription drug from a formulary at any time if:
(1) The drug is not approved by the United States Food and Drug Administration;
(2) The United States Food and Drug Administration issues a notice, guidance, warning, announcement or any other statement about the drug which calls into question the clinical safety of the drug; or
(3) The prescription drug is approved by the United States Food and Drug Administration for use without a prescription.
(b) If the individual carrier's formulary includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to the prescription drugs in each tier, move a brand name prescription drug to a tier with a larger deductible, copayment or coinsurance if the individual carrier adds to the formulary a generic prescription drug that is approved by the United States Food and Drug Administration for use as an alternative to the brand name prescription drug at:
(1) The benefit tier from which the brand name prescription drug is being moved; or
(2) A benefit tier that has a smaller deductible, copayment or coinsurance than the benefit tier from which the brand name prescription drug is being moved.
3. This section does not prohibit an individual carrier from adding a prescription drug to a formulary at any time.
4. This section does not apply to a grandfathered plan.
5. As used in this section:
(a) "Health benefit plan" has the meaning ascribed to it in NRS 687B.470.
(b) "Individual carrier" has the meaning ascribed to it in NRS 689A.550.

Nev. Admin. Code § 689A.425

Added to NAC by Comm'r of Insurance by R074-14, eff. 1/1/2016

NRS 679B.130, 687B.120, 689A.710